- Home
- ETNB vs QDEL Comparison
ETNB vs QDEL Comparison
Compare ETNB & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETNB
- QDEL
- Stock Information
- Founded
- ETNB 2018
- QDEL 1979
- Country
- ETNB United States
- QDEL United States
- Employees
- ETNB N/A
- QDEL N/A
- Industry
- ETNB Biotechnology: Pharmaceutical Preparations
- QDEL Medical Specialities
- Sector
- ETNB Health Care
- QDEL Health Care
- Exchange
- ETNB Nasdaq
- QDEL Nasdaq
- Market Cap
- ETNB 2.2B
- QDEL 2.1B
- IPO Year
- ETNB 2019
- QDEL N/A
- Fundamental
- Price
- ETNB $14.80
- QDEL $30.61
- Analyst Decision
- ETNB Buy
- QDEL Hold
- Analyst Count
- ETNB 10
- QDEL 6
- Target Price
- ETNB $22.31
- QDEL $39.00
- AVG Volume (30 Days)
- ETNB 3.5M
- QDEL 1.3M
- Earning Date
- ETNB 11-07-2025
- QDEL 11-05-2025
- Dividend Yield
- ETNB N/A
- QDEL N/A
- EPS Growth
- ETNB N/A
- QDEL N/A
- EPS
- ETNB N/A
- QDEL N/A
- Revenue
- ETNB N/A
- QDEL $2,741,600,000.00
- Revenue This Year
- ETNB N/A
- QDEL N/A
- Revenue Next Year
- ETNB N/A
- QDEL $2.65
- P/E Ratio
- ETNB N/A
- QDEL N/A
- Revenue Growth
- ETNB N/A
- QDEL N/A
- 52 Week Low
- ETNB $4.16
- QDEL $22.05
- 52 Week High
- ETNB $15.06
- QDEL $49.45
- Technical
- Relative Strength Index (RSI)
- ETNB 75.79
- QDEL 62.32
- Support Level
- ETNB $14.74
- QDEL $25.48
- Resistance Level
- ETNB $14.85
- QDEL $30.85
- Average True Range (ATR)
- ETNB 0.06
- QDEL 1.21
- MACD
- ETNB -0.20
- QDEL 0.25
- Stochastic Oscillator
- ETNB 33.33
- QDEL 98.32
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.